These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 27776922)

  • 21. The broadening application of chemodenervation in X-linked dystonia-parkinsonism (Part II): an open-label experience with botulinum toxin-A (Dysport®) injections for oromandibular, lingual, and truncal-axial dystonias.
    Rosales RL; Ng AR; Santos MM; Fernandez HH
    Int J Neurosci; 2011; 121 Suppl 1():44-56. PubMed ID: 21348790
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Botulinum Neurotoxin Therapy for Lingual Dystonia Using an Individualized Injection Method Based on Clinical Features.
    Yoshida K
    Toxins (Basel); 2019 Jan; 11(1):. PubMed ID: 30658420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Botulinum toxin treatment for upper airway collapse resulting from temporomandibular joint dislocation due to jaw-opening dystonia.
    Yoshida K; Iizuka T
    Cranio; 2006 Jul; 24(3):217-22. PubMed ID: 16933464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oromandibular Dystonia Causing Recurrent Mandibular Open Lock in Two Adolescents Managed with Botulinum Toxin.
    Perez CV; Okeson J
    J Dent Child (Chic); 2019 Jan; 86(1):47-52. PubMed ID: 30992101
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Botulinum toxin A for patients with orofacial dystonia: prospective, observational, single-centre study.
    Ruiz-de-León-Hernández G; Díaz-Sánchez RM; Torres-Lagares D; Hernández-Pacheco E; González-Martín M; Serrera-Figallo MA
    Int J Oral Maxillofac Surg; 2018 Mar; 47(3):386-391. PubMed ID: 29208327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical experience with patients with spasmodic dysphonia and primary Meige syndrome.
    Pedrero-Escalas MF; García-López I; Santiago-Pérez S; Vivancos F; Gavilán J
    Acta Otorrinolaringol Esp (Engl Ed); 2019; 70(1):1-5. PubMed ID: 29716720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of botulinum toxin type-B in the treatment of patients who have become unresponsive to botulinum toxin type-A -- initial experiences.
    Barnes MP; Best D; Kidd L; Roberts B; Stark S; Weeks P; Whitaker J
    Eur J Neurol; 2005 Dec; 12(12):947-55. PubMed ID: 16324088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of oromandibular dystonia with botulinum toxin A improves apnea in a teenager with quadriplegic cerebral palsy: A case report.
    Roberts J; Tenaglia A; Bellissimo E; Kim H
    J Pediatr Rehabil Med; 2024; 17(1):125-129. PubMed ID: 37522227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patient benefit from treatment with botulinum neurotoxin A for functional indications in otorhinolaryngology.
    Braun T; Gürkov R; Hempel JM; Berghaus A; Krause E
    Eur Arch Otorhinolaryngol; 2010 Dec; 267(12):1963-7. PubMed ID: 20563590
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative electromyography-guided botulinum toxin treatment of cervical dystonia.
    Finsterer J; Fuchs I; Mamoli B
    Clin Neuropharmacol; 1997 Feb; 20(1):42-8. PubMed ID: 9037572
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The use of botulinum toxin A in the treatment of focal dystonias].
    Sławek J; Duzyński W
    Neurol Neurochir Pol; 1997; 31(2):207-15. PubMed ID: 9380251
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polyradiculoneuritis after botulinum toxin therapy for cervical dystonia.
    Burguera JA; Villaroya T; López-Alemany M
    Clin Neuropharmacol; 2000; 23(4):226-8. PubMed ID: 11020130
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact on quality of life of botulinum toxin treatments for spasmodic dysphonia and oromandibular dystonia.
    Bhattacharyya N; Tarsy D
    Arch Otolaryngol Head Neck Surg; 2001 Apr; 127(4):389-92. PubMed ID: 11296046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Botulinum toxin treatment of axial and cervical dystonia.
    Benecke R; Dressler D
    Disabil Rehabil; 2007 Dec; 29(23):1769-77. PubMed ID: 18033602
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low-dose treatment of cervical dystonia, blepharospasm and facial hemispasm with albumin-diluted botulinum toxin type A under EMG guidance. An open label study.
    Rollnik JD; Matzke M; Wohlfarth K; Dengler R; Bigalke H
    Eur Neurol; 2000; 43(1):9-12. PubMed ID: 10601802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Laryngeal dystonia: case report and treatment with botulinum toxin.
    Santos VJ; Mattioli FM; Mattioli WM; Daniel RJ; Cruz VP
    Braz J Otorhinolaryngol; 2006; 72(3):425-7. PubMed ID: 17119783
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pilot Single-Blind Trial of AbobotulinumtoxinA in Oromandibular Dystonia.
    Scorr LM; Silver MR; Hanfelt J; Sperin E; Freeman A; Jinnah HA; Factor SA
    Neurotherapeutics; 2018 Apr; 15(2):452-458. PubMed ID: 29542022
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence-based medicine in botulinum toxin therapy for cervical dystonia.
    Ceballos-Baumann AO
    J Neurol; 2001 Apr; 248 Suppl 1():14-20. PubMed ID: 11357233
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atypical posttraumatic dystonia treated successfully by botulinum toxin injection.
    Lee SY; Lim JY
    Am J Phys Med Rehabil; 2015 Mar; 94(3):246-9. PubMed ID: 25415396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Botulinum A toxin in the treatment of focal dystonias].
    Domzał TM
    Neurol Neurochir Pol; 1998; 32 Suppl 1():35-44. PubMed ID: 9608551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.